1. BCL2-BH4 antagonist BDA-366 suppresses human myeloma growth
   Jiusheng Deng et al, 2016, Oncotarget CrossRef
2. Dihydroartemisinin Induces Growth Arrest and Overcomes Dexamethasone Resistance in Multiple Myeloma
   Ying Chen et al, 2020, Frontiers in Oncology CrossRef